Rutherford, N.J., November 7, 2015 – Cancer Genetics, Inc. (Nasdaq: CGIX; “CGI” or “The Company”), an emerging leader in DNA-based cancer diagnostics, announced the presentation of results from a University of Utah (Huntsman Cancer Institute)-led research study at the 14th International Kidney Cancer Symposium in Miami, Florida, on November 7th, 2015. The study entitled, “Molecular Predictors of […]
Rutherford, N.J., November 6, 2015 – Cancer Genetics, Inc. (Nasdaq: CGIX; “CGI” or “The Company”), an emerging leader in DNA-based cancer diagnostics, announced the presentation of results from two Cancer Genetics-led research studies at the 2015 Association for Molecular Pathology Meeting, taking place in Austin, Texas on November 5th-7th. The first study, entitled, “A Multi-Platform Approach […]
RUTHERFORD, NJ – November 3, 2015 – Cancer Genetics, Inc., an emerging leader in DNA-based cancer diagnostics, announced today that it will report financial results for the third quarter ended September 30, 2015 before the market opens on Tuesday, November 10, 2015. The company will hold a live investor conference call and webcast at 8:30am […]
Each year in the United States more than 55 million Pap smears are performed, of which 3.5 million have abnormal or unclear results The FHACT® test will be available immediately through CGI’s expanded National Clinical Sales Force RUTHERFORD, N.J., October 28, 2015 — Cancer Genetics, Inc. (Nasdaq:CGIX; “CGI” or “the Company”), an emerging leader in […]
“The Response Genetics team is excited to become a part of the CGI family, to continue to expand our oncology-focused molecular diagnostic services and the delivery of information to improve patient insights and outcomes,” said Alan Cheeks, Vice President of Operations.
RUTHERFORD, N.J., October 9, 2015 — Edward J. Sitar, CFO, for Cancer Genetics, Inc. was named the winner in the Public Company category for the 2015 NJBIZ CFO of the Year awards program. The awards program, produced by NJBIZ, New Jersey’s premier business news publication, was presented by WithumSmith+Brown, PC and sponsored by Aon Risk […]
RUTHERFORD, N.J., October 2, 2015 — Cancer Genetics, Inc. (Nasdaq:CGIX; “CGI” or “the Company”), an emerging leader in DNA-based cancer diagnostics, announced today that it received approval from the United States bankruptcy court in Delaware to purchase substantially all of the assets of Los Angeles-based Response Genetics, Inc. (“RGI”). In connection with the transaction, CGI also agreed […]
Rutherford, N.J., September 17, 2015 – Cancer Genetics, Inc. (Nasdaq: CGIX; “CGI” or “The Company”), an emerging leader in DNA-based cancer diagnostics, announced today the presentation of results from two independent cervical cancer-related studies during the 30th International Papillomavirus Conference & Clinical and Public Health Workshops (HPV 2015) scheduled to take place on September 17-21, […]
“We are very pleased to announce our relationship with BCBS of Illinois, the largest and most experienced health insurance company in Illinois. Blue Cross Blue Shield of Illinois is committed to the highest standards of business ethics and integrity, as well as to fulfilling their corporate citizenship responsibilities to the communities it serves,” said Randy Goodman, Ph.D., Director of Reimbursement and Clinical Revenue Cycle Management at Cancer Genetics, Inc. “
Panna Sharma, President and CEO will present at the 2015 Sidoti Emerging Growth Conference.
“Our market penetration and revenue trajectory, which are driven by both strong organic growth and meaningful contributions from our recent acquisitions, continue to expand significantly. This continued growth is achieved all while we remain focused on further advancing our already unrivaled portfolio of genomic capabilities in oncology,” continued Sharma.
▪ Response Genetics’ Los Angeles clinical lab and facility will allow Cancer Genetics to expand its national sales and service footprint and serve a broader customer base while adding immediate revenue from both clinical and biopharma customers
▪ The transaction is expected to add an additional $10 to $12 million in revenue to CGI over the next year and is expected to close in early October
CGI will report financial results for the second quarter ended June 30, 2015 before the market open on Tuesday, August 11, 2015. The company will also hold a live investor conference call and webcast at 8:30am Eastern.
The presentation will take place on Monday, August 3rd at 10:15am (Mountain Time) at the Cancer Genomics Consortium and the Cytogenomics Array Group Meeting (CGC-CAGdb) in Denver, Colorado.
“Our team and many of our customers are very enthusiastic about Dr. Shaknovich joining CGI,” said Panna Sharma. “Her expertise at the vanguard of genomic research and clinical translation makes her uniquely suited to help CGI fulfill our mission and help further integrate our clinical and research efforts.”
The companies have entered into an agreement to offer biotech and pharmaceutical clients access to ICON Laboratory Services’ global central laboratory experience combined with Cancer Genetic’s expertise in oncology testing and genomic assay development.
“CGI has built deep expertise in CLL diagnosis, prognosis and theranosis through our work with both the clinical and biopharma community. This recent award is a testament to our team and our ability to provide actionable biomarker information that helps our biopharma partners,” said Panna Sharma, President and CEO of Cancer Genetics. “CLL is an […]
RUTHERFORD, N.J., June 1, 2015 — Cancer Genetics, Inc. (Nasdaq: CGIX; “CGI” or “The Company”), an emerging leader in DNA-based cancer diagnostics, today announced that Panna Sharma, President and Chief Executive Officer, will present at the Jefferies 2015 Global Healthcare Conference. The presentation will take place at the Grand Hyatt New York on Thursday, June […]
RUTHERFORD, N.J., May 29, 2015 — Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), an emerging leader in DNA-based cancer diagnostics, announced today the presentation of results from a research collaboration with Memorial Sloan Kettering Cancer Center at the 2015 American Society of Clinical Oncology Annual Meeting, taking place at the McCormick Place Convention Center […]
RUTHERFORD, N.J. & HYDERABAD, INDIA, May 26, 2015 – Cancer Genetics, Inc. (Nasdaq: CGIX; “CGI” or the “Company”) announced today that it was selected by Japanese regenerative medicine company, ReproCELL, Inc., to provide next-generation sequencing (NGS) based services and molecular information to enhance ReproCELL’s translational medicine initiatives. Under the terms of the agreement, CGI will […]